• Dabigatran in Thromboembolism: Evidence and AF Practice

  2026-08-19

  The 2015 review by Enriquez and colleagues synthesizes the pharmacology, clinical trial evidence, pharmacokinetics, and safety considerations surrounding dabigatran, the first widely introduced non-vitamin K oral anticoagulant. Its main practical contribution is to show how direct thrombin inhibition can provide effective thromboembolism prevention with predictable dosing, while also emphasizing renal clearance, drug interactions, and bleeding management.

• Carbapenemase Transmission in CREC, Guangdong

  2026-08-19

  Chen et al. characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates collected from eight teaching hospitals in Guangdong during 2022–2024. The study links predominantly plasmid-associated blaNDM-1 with multidrug resistance, high conjugative transfer potential, and genetically related hospital isolates, while also defining important limits for interpreting local transmission data.

• PPACK Dihydrochloride as a Thrombin Timing Gate

  2026-08-18

  PPACK Dihydrochloride is more than an irreversible thrombin inhibitor: it can function as a temporal control for separating thrombin-dependent coagulation from platelet P2-receptor signaling. This article develops an assay-design framework grounded in the NF449 platelet study and practical experimental interpretation.

• Sulfo-Cy5 NHS Ester for Immune-Cell Imaging

  2026-08-17

  Sulfo-Cy5 NHS ester enables aqueous protein conjugation and high-contrast cellular imaging without routine organic co-solvents. This guide connects its labeling chemistry to assay design for VLA-4 localization and immune-microenvironment studies.

• Azilsartan medoxomil monopotassium: Lab Guide

  2026-08-17

  This scenario-driven guide explains how Azilsartan medoxomil monopotassium, SKU B1071, can improve the interpretability of cell viability, proliferation, and cytotoxicity workflows involving AT1 receptor biology. It connects receptor-binding evidence with practical formulation, dosing, solvent, storage, and vendor-selection decisions.

• Meropenem trihydrate in Resistance Research

  2026-08-16

  Build reproducible workflows for susceptibility testing, resistance phenotyping, and LC-MS/MS metabolomics with a broad-spectrum carbapenem antibiotic. Practical guidance connects meropenem exposure design with CPE biomarker discovery, while keeping formulation, stability, and translational limitations visible.

• Prochlorperazine in Melanoma Research Workflows

  2026-08-15

  Prochlorperazine combines dopamine D2 receptor antagonism with experimentally useful effects on melanoma viability, motility, MITF, and tyrosinase. This workflow-oriented guide shows how to build reproducible concentration-response, wound-healing, and protein-expression assays while avoiding solvent, formulation, and interpretation errors.

• Imatinib (STI571) for Reliable Kinase Assays

  2026-08-14

  A scenario-based guide to using Imatinib (STI571), SKU B2171, in cell viability, proliferation, cytotoxicity, and kinase-signaling workflows. It connects target potency, formulation, controls, protocol parameters, and CML-related interpretation to improve experimental consistency without overstating what a viability endpoint can prove.

• PDGF-BB: Murine Recombinant Protein for Vascular Assays

  2026-08-14

  Use murine recombinant PDGF-BB as a defined mitogenic comparator for smooth muscle and connective-tissue cell models, then layer it with hypoxia or metabolic stress to dissect vascular remodeling. This workflow connects receptor-driven proliferation with the lactate–ALDOB–DRP1 biology highlighted in pulmonary hypertension research.

• Silk Fibroin–Ce6 Films for Infected Wound Healing

  2026-08-13

  The reference study developed an aligned silk fibroin electrospun film conjugated with Chlorin e6 (Ce6) for light-activated treatment of Staphylococcus aureus-infected wounds. Its significance lies in combining directional cell guidance, reactive oxygen species generation, antibacterial photodynamic therapy, and later-stage macrophage modulation within one biomaterial platform.

• Oxaliplatin: From DNA Damage to Translation

  2026-08-13

  Oxaliplatin is more than a cytotoxic reagent: it is a mechanistic probe for DNA damage, apoptosis, treatment resistance, and biomarker-guided translation. This thought-leadership guide connects its platinum-DNA adduct activity with SMC2 and SMC4 findings in breast cancer, practical validation strategies, and more predictive cancer chemotherapy research.

• Ibotenic acid: Reliable Assay Design

  2026-08-12

  Learn how Ibotenic acid, SKU B6246, can support controlled glutamatergic challenge experiments while reducing variability from identity, solubility, and stock-handling errors. This scenario-based guide connects cell viability assay practice with circuit-level neuroscience evidence and practical vendor-selection criteria.

• CPI-613 Workflows for Tumor Metabolism

  2026-08-12

  Build reproducible CPI-613 experiments that connect mitochondrial enzyme inhibition with ATP loss, membrane-potential collapse, apoptosis, and tumor–macrophage signaling. The workflow combines practical dose-finding with a cholangiocarcinoma-focused strategy for testing PDHA1-linked metabolic and chemotherapy-resistance mechanisms.

• Gingerenone A Re-sensitizes RCC to Sunitinib

  2026-08-11

  This January 2026 study identifies gingerenone A as an LDHA-directed metabolic inhibitor that suppresses glycolysis and restores sunitinib activity in renal cell carcinoma models. Its combination of target-discovery analysis, metabolic rescue experiments, drug-synergy testing, and in vivo validation supports glycolysis as a practical strategy for addressing TKI resistance.

• Oleanolic Acid in Dual-Loaded Liposome Workflows

  2026-08-11

  Learn how to handle Oleanolic acid as a DMSO-soluble triterpenoid and incorporate it into dual-loaded liposome research. A validated nanoparticle exclusion chromatography workflow helps distinguish free compound from encapsulated cargo when lipophilic and hydrophilic drugs are analyzed together.

16700 records 1/1114 page Next 12345 下5页 Last page